Provided by Tiger Trade Technology Pte. Ltd.

ASCENTAGE-B

47.620
+1.3202.85%
Volume:1.46M
Turnover:69.17M
Market Cap:17.76B
PE:-35.48
High:48.300
Open:46.300
Low:45.740
Close:46.300
52wk High:95.350
52wk Low:31.350
Shares:373.00M
HK Float Shares:373.00M
Volume Ratio:1.40
T/O Rate:0.39%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.342
ROE:-159.65%
ROA:-22.77%
PB:23.57
PE(LYR):-35.48
PS:40.19

Loading ...

Company Profile

Company Name:
ASCENTAGE-B
Exchange:
SEHK
Establishment Date:
2009
Employees:
605
Office Location:
Suzhou Industrial Park,68 Xinqing Road,Suzhou,Jiangsu Province,China
Zip Code:
215000
Fax:
- -
Introduction:
Ascentage Pharma Group International is an investment holding company primarily engaged in the discovery, development, and commercialization of therapies for hematologic malignancies. The Company's main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918, and APG-2449. The Company's products are primarily used to treat chronic myeloid leukemia (CML), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS) and multiple myeloma (MM). The Company primarily conducts its businesses in domestic market.

Directors

Name
Position
Dajun Yang
Chairman, Chief Executive Officer and Director
Changqing Ye
Independent Non-executive Director
David Sidransky
Lead Independent Non-executive Director
Debra Yu
Independent Non-executive Director
Marc E. Lippman
Independent Non-executive Director
Marina S. Bozilenko
Independent Non-executive Director
Shaomeng Wang
Non-executive Director
Simon Dazhong Lu
Non-executive Director
Wei Ren
Independent Non-executive Director

Shareholders

Name
Position
Dajun Yang
Chairman, Chief Executive Officer and Director
Eric Huang
Senior Vice President of Global Corporate Development and Finance
Thomas J. Knapp
Senior Vice President, General Counsel
Veet Misra
Chief Financial Officer
Jin Cao
Head of Finance
Raymond Jeffrey Kmetz
Chief Business Officer
Yifan Zhai
Chief Medical Officer